Hypertrophic Cardiomyopathy (HCM) is the most common genetic heart disease and affects 1 in 500 individuals. The disease can run in families and is a leading cause of adolescent sudden cardiac death.
The HCM program at Sibley Heart Center diagnoses and manages patients who either currently have HCM or a family history of the condition. As part of the program, patients have access to comprehensive care from HCM experts.
If a genetic case of the disease is identified, HCM program staff members can provide genetic screening to determine if other family members are at risk for developing the disease. If adult family members are determined to be at risk, or are diagnosed with HCM, our team works with the Emory Hypertrophic Cardiomyopathy Clinic, which is focused on providing high quality care for adult HCM patients.
Each member of our team plays a key role in the diagnosis and treatment of our patients. Team members include:
- Pediatric cardiologists who specialize in HCM, cardiac MRI (to evaluate HCM) and stress echocardiography (to determine the extent of the patients disease through exercise stress testing.)
- Pediatric cardiac genetic counselors who evaluate a patient's family history and test to determine if the patient's condition is genetic
- Pediatric nurses and ultrasonographers who perform comprehensive electrocardiograms, echocardiograms and Holter monitoring